Francesco Marincola, Refuge Biotechnologies, USA
Aims and scope
Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. We publish research that focuses on the biology of disease, as well as preclinical and basic research that is closely associated with medicine. Translational Medicine Communications will also consider reviews, methodology articles, protocols and commentaries.
Our aim is to improve transparency and reproducibility within translational medicine, which is why we consider research papers regardless of outcome or significance of findings, as well as protocols for future research. We aim to serve the translational science community by publishing all scientifically valid and technically sound articles and we are dedicated to facilitating the communication between basic and clinical science.
Articles
-
-
N-acetyl cysteine prevents pain and hypersensitivity of bleaching agents without affecting their aesthetic appeal; evidence from in vitro to animal studies and to human clinical trials
-
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
-
Preliminary report of a novel formulation of clinical-grade, fully matured, tumor-associated peptide-loaded dendritic cells for cancer immunotherapy
-
Forming effective relationships between academia and the medical devices industry with a focus on launching a smart heart valve prosthesis for pediatric patients
-
Total lymphocyte count in cancer patients with lymphopenia treated with intravenous vitamin C: Results of an observational study
-
Comparative in vitro cytotoxic, anti-inflammatory and anti-microbiological activities of two indigenous Venda medicinal plants
-
CD8+ tumor infiltrating lymphocytes strongly correlate with molecular subtype and clinico-pathological characteristics in breast cancer patients from Sudan
-
Membrane cholesterol depletion reduces breast tumor cell migration by a mechanism that involves non-canonical Wnt signaling and IL-10 secretion
-
Analytical validation of an mRNA-based urine test to predict the presence of high-grade prostate cancer
Editor-in-Chief
Journal of Translational Medicine
Translational Medicine Communications is the companion journal to Journal of Translational Medicine.
Advertisement
Annual Journal Metrics
-
Speed
38 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
89 days from submission to acceptance
18 days from acceptance to publication
Usage
15,184 Downloads
3 Altmetric mentions
Advertisement
